Competitive antagonist of NMDA receptors, CGP 37849 and CGP 39551, enhance the anticonvulsant activity of valproate against electroconvulsions in mice

This publication has 22 references indexed in Scilit:

• Anticonvulsant activity of the NMDA antagonists, d(−)4-(3-phosphonopropyl)piperazine-2-carboxylic acid (D-CPP) and d(−)(E)-4-(3-phosphonoprop-2-enyl) piperazine-2-carboxylic acid (D-CPPene) in a rodent and a primate model of reflex epilepsy
  Epilepsy Research, 1990
• Excitatory amino acid antagonists protect mice against seizures induced by bicuculline
  Brain Research, 1990
• NMDA receptor antagonists and limbic status epilepticus: a comparison with standard anticonvulsants
  Epilepsy Research, 1990
• Synthesis and NMD A Antagonistic Properties of the Enantiomers of 4‐(3‐phosphonopropyl)piperazine‐2‐carboxylic acid (CPP) and of the unsaturated analogue (E)‐4‐(3‐phosphonoprop‐2‐enyl)piperazine‐2‐carboxylic acid (CPP‐ene)
  Helvetica Chimica Acta, 1989
• CPP, a new potent and selective NMDA antagonist. Depression of central neuron responses, affinity for [3H]d-AP5 binding sites on brain membranes and anticonvulsant activity
  Brain Research, 1986
• Benzodiazepine impairs and β-carboline enhances performance in learning and memory tasks
  Nature, 1986
• Kindling-like stimulus patterns induce epileptiform discharges in the guinea pig in vitro hippocampus
  Neuroscience Letters, 1985
• Epilepsy and the concentrations of plasma amino acids in humans
  Neurochemistry International, 1982
• Anticonvulsant Action of Excitatory Amino Acid Antagonists
  Science, 1982
• Une nouvelle méthode simple pour explorer l’action «tranquillisante»: le test de la cheminée
  Pharmacology, 1960